Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) Stock Analysis

Sector: HEALTHCARE - DRUG MANUFACTURERS - SPECIALTY & GENERIC

Exchange: NYSE

Key Metrics

Market Sentiment

Amneal Pharmaceuticals, Inc. Class A Common Stock currently has a Bullish sentiment score of 0.50.

About Amneal Pharmaceuticals, Inc. Class A Common Stock

Amneal Pharmaceuticals, Inc. (AMRX) is a prominent developer and manufacturer focused on delivering high-quality generic and specialty pharmaceuticals across diverse therapeutic areas and dosage forms. Based in Bridgewater, New Jersey, the company utilizes its robust expertise in drug development and operational excellence to provide affordable medication solutions to patients and healthcare providers. With a commitment to innovation and responsiveness to market demands, Amneal is strategical...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Amneal Pharmaceuticals, Inc. Class A Common Stock and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does AMRX pay dividends?

Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) does not currently pay a regular dividend.

What is AMRX's P/E ratio?

Amneal Pharmaceuticals, Inc. Class A Common Stock has a price-to-earnings (P/E) ratio of 1458.00.

What is AMRX's market cap?

Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) has a market capitalization of $4.58B with a current stock price of $14.49.